M. Moir et Rh. Holbrook, EFFECT OF NICARDIPINE ON THE REVERSAL OF MAGNESIUM TOXICITY BY CALCIUM GLUCONATE IN NONPREGNANT RABBITS, Obstetrics and gynecology, 82(1), 1993, pp. 67-70
Objective: To determine whether nicardipine, a dihydropyridine, inhibi
ts the ability of calcium gluconate to reverse magnesium-induced toxic
ity. Methods: The reversal of magnesium-induced neuromuscular blockade
of skeletal muscle in the presence of nicardipine was assessed using
a nerve stimulator. Nicardipine (12 mg) or an equivalent volume of sal
ine was administered intramuscularly to 19 nonpregnant rabbits in a ra
ndomized, blinded manner. Magnesium sulfate, 800 mg, was then infused
intravenously in all animals, an amount sufficient to cause toxicity a
s measured by depression of skeletal muscle twitch and by average seru
m levels of 10.4 mEq/L. Calcium gluconate (300 mg) was then infused in
all animals, and reversal of neuromuscular blockade was measured usin
g the nerve stimulator to compare the saline- and nicardipine-treated
groups.Results: Administration of calcium gluconate was equally effect
ive in reversing magnesium-induced toxicity in both the control and te
st groups. Conclusion: Nicardipine does not block the ability of calci
um gluconate to reverse magnesium-induced neuromuscular blockade.